Key terms
About ADXN
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADXN news
No recent news articles are available for ADXN
No recent press releases are available for ADXN
ADXN Financials
Key terms
Ad Feedback
ADXN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADXN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range